The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A cell cycle-related RNA expression signature of neoantigen burden in lung adenocarcinoma.
 
Michael F Sharpnack
Employment - Delpor (I)
 
Travis Johnson
No Relationships to Disclose
 
Gregory Alan Otterson
Consulting or Advisory Role - Amgen (Inst); Merck (Inst); Novartis (Inst); Takeda (Inst)
Research Funding - Acerta Pharma (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Genentech/Roche (Inst); Ignyta (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst)
 
David Paul Carbone
Consulting or Advisory Role - Bayer; Bayer; Biothera; Biothera; Boehringer Ingelheim; Boehringer Ingelheim; Bristol-Myers Squibb; Bristol-Myers Squibb; Clovis Oncology; Clovis Oncology; Genentech/Roche; Genentech/Roche; Merck; Merck; Novartis; Novartis; Peregrine Pharmaceuticals; Peregrine Pharmaceuticals; Pfizer; Pfizer; Synta; Synta
Research Funding - Bristol-Myers Squibb
 
Kun Huang
No Relationships to Disclose
 
Kai He
Honoraria - Geneplus
Consulting or Advisory Role - Perthera
Research Funding - Adaptimmune (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Mirati Therapeutics (Inst)